|
DNA Sequencing In Drug Discovery: Market outlook for applications, tools and services, and 40 company profiles
Published Dec 2009
The advent of DNA sequencing technology has had a vast impact on the field of drug development. It has played a key role in the success of the Human Genome Project, which has made it an essential tool for genetic analysis. Advanced technological developments in microarrays, bioinformatics and similar tools have increased the scope of applications and services.
More>>
|
|
|
|
Single Cell Analysis 2010: the New Frontier for 'Omics Market Report
Published Jan 2010
Successful conversion of opportunity to profit requires a detailed understanding of this emerging market. Single-Cell Analysis 2010: the New Frontier for ’Omics explains the key technologies, applications, unmet needs and trends. The 128-page report includes a survey of more than 300 participants, interviews with 5 leading experts, analyses of 25 companies and 16 academic programs and a 5-by-7 quantitative market model of technologies and applications.
More>>
|
|
|
|
Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
Published March 2010
There has been a significant transition in the diagnostic techniques created with increasing technological innovations. In the future, the focus will be on genetic study and disease predisposition, which will test patients' probability of acquiring a disease or a disorder, enabling precautionary steps.
More>>
|
|
|
|
The Clinical Trials Market 2006
Published
The global clinical trials industry is currently worth an estimated $10 billion and has the potential for considerable growth in the future. Global revenues from clinical trials have increased by almost 15% in the last year and the industry is prepared for an extended period of healthy growth. Concern over safety and an extremely competitive pharmaceutical market has driven demand for large clinical trials but will also radically change how clinical trials are regulated and designed.
More>>
|
|
|
|
How to Succeed in Personalized Medicine by Using Tools and Technologies
Published January 2006
D&MD's How to Succeed in Personalized Medicine by Using Tools and Technologies market analysis report provides a clear understanding of the regulatory and commercial influences, elements shaping this growing market and offers an intensive investigation of pharmacogenomic business issues.
More>>
|
|
|
|
Organic and Medicinal Chemistry in Drug Discovery
Published October 2005
D&MD's Organic and Medicinal Chemistry in Drug Discovery market analysis report investigates the methods and technologies currently used to craft compound collections as well as the products and services available to support pharmaceutical chemistry programs.
More>>
|
|
|
|
Drug Targets from Genomics - Evolving Tools for Discovery
Published August 2005
Drug Targets from Genomics: Evolving Tools for Discovery seeks to examine the roles omic technologies play in pharma R&D, to assess their value to pharma, and to predict their future role and value. This Report analyzes current and projected revenues from sales of omic technology-based products (reagents and consumables), which in 2004 totaled nearly $1.5 billion.
More>>
|
|
|
|
Solving Drug Discovery with Metabolomics and Metabonomics
Published February 2005
There has been an 'omics' explosion. With the advent of genomics, proteomics, transcriptomics, there is also now metabolomics and metabonomics. These terms are the newest sibling to genomics and proteomics and are supposed to embody metabolic profiling.
More>>
|
|
|